Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674. https://doi.org/10.1016/j.cell.2011.02.013
Article CAS PubMed Google Scholar
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12(1), 31–46. https://doi.org/10.1158/2159-8290.CD-21-1059
Article CAS PubMed Google Scholar
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57–70. https://doi.org/10.1016/s0092-8674(00)81683-9
Article CAS PubMed Google Scholar
Yuan, S., Norgard, R. J., & Stanger, B. Z. (2019). Cellular plasticity in cancer. Cancer Discov, 9(7), 837–851. https://doi.org/10.1158/2159-8290.CD-19-0015
Article CAS PubMed Google Scholar
Filip, S., Mokry, J., Horacek, J., & English, D. (2008). Stem cells and the phenomena of plasticity and diversity: A limiting property of carcinogenesis. Stem Cells Dev, 17(6), 1031–1038. https://doi.org/10.1089/scd.2007.0234
Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133(4), 704–715. https://doi.org/10.1016/j.cell.2008.03.027
Article CAS PubMed PubMed Central Google Scholar
Pastushenko, I., & Blanpain, C. (2019). EMT transition states during tumor progression and metastasis. Trends in Cell Biology, 29(3), 212–226. https://doi.org/10.1016/j.tcb.2018.12.001
Article CAS PubMed Google Scholar
Mansoori, B., Mohammadi, A., Davudian, S., Shirjang, S., & Baradaran, B. (2017). The different mechanisms of cancer drug resistance: A brief review. Adv Pharm Bull, 7(3), 339–34. https://doi.org/10.15171/apb.2017.041
Article CAS PubMed PubMed Central Google Scholar
Bordoloi, D., Roy, N. K., Monisha, J., Padmavathi, G., & Kunnumakkara, A. B. (2016). Multi-targeted agents in cancer cell chemosensitization: What we learnt from curcumin thus far. Recent Patents on Anti-Cancer Drug Discovery, 11(1), 67–97. https://doi.org/10.2174/1574892810666151020101706
Article CAS PubMed Google Scholar
Kunnumakkara, A. B., Bordoloi, D., Sailo, B. L., Roy, N. K., Thakur, K. K., Banik, K., et al. (2019). Cancer drug development: The missing links. Experimental Biology and Medicine (Maywood, N.J.), 244(8), 663–689. https://doi.org/10.1177/1535370219839163
Article CAS PubMed Google Scholar
Longley, D. B., & Johnston, P. G. (2005). Molecular mechanisms of drug resistance. The Journal of Pathology, 205(2), 275–292. https://doi.org/10.1002/path.1706
Article CAS PubMed Google Scholar
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schutz, G., Umesono, K., et al. (1995). The nuclear receptor superfamily: The second decade. Cell, 83(6), 835–839. https://doi.org/10.1016/0092-8674(95)90199-x
Article CAS PubMed PubMed Central Google Scholar
Hoeck, J. D., Biehs, B., Kurtova, A. V., Kljavin, N. M., de Sousa, E. M. F., Alicke, B., et al. (2017). Stem cell plasticity enables hair regeneration following Lgr5(+) cell loss. Nature Cell Biology, 19(6), 666–676. https://doi.org/10.1038/ncb3535
Article CAS PubMed Google Scholar
Ge, Y., & Fuchs, E. (2018). Stretching the limits: From homeostasis to stem cell plasticity in wound healing and cancer. Nature Reviews Genetics, 19(5), 311–325. https://doi.org/10.1038/nrg.2018.9
Article CAS PubMed PubMed Central Google Scholar
Brockmueller, A., Sajeev, A., Koklesova, L., Samuel, S. M., Kubatka, P., Busselberg, D., et al. (2023). Resveratrol as sensitizer in colorectal cancer plasticity. Cancer and Metastasis Reviews. https://doi.org/10.1007/s10555-023-10126-x
Shen, S., & Clairambault, J. (2020). Cell plasticity in cancer cell populations. F1000Research, 9, F1000 Faculty Rev-635. https://doi.org/10.12688/f1000research.24803.1
Article CAS PubMed PubMed Central Google Scholar
Gupta, P. B., Pastushenko, I., Skibinski, A., Blanpain, C., & Kuperwasser, C. (2019). Phenotypic plasticity: Driver of cancer initiation, progression, and therapy resistance. Cell Stem Cell, 24(1), 65–78. https://doi.org/10.1016/j.stem.2018.11.011
Article CAS PubMed Google Scholar
Zeng, Z., Fu, M., Hu, Y., Wei, Y., Wei, X., & Luo, M. (2023). Regulation and signaling pathways in cancer stem cells: Implications for targeted therapy for cancer. Molecular Cancer, 22(1), 172. https://doi.org/10.1186/s12943-023-01877-w
Article CAS PubMed PubMed Central Google Scholar
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001). Stem cells, cancer, and cancer stem cells. Nature, 414(6859), 105–111. https://doi.org/10.1038/35102167
Article CAS PubMed Google Scholar
Dawood, S., Austin, L., & Cristofanilli, M. (2014). Cancer stem cells: implications for cancer therapy. Oncology (Williston Park, N.Y.), 28(12), 1101–1110.
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A, 100(7), 3983–3988. https://doi.org/10.1073/pnas.0530291100
Article CAS PubMed PubMed Central Google Scholar
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432(7015), 396–401. https://doi.org/10.1038/nature03128
Article CAS PubMed Google Scholar
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., et al. (2007). CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Research, 67(9), 4010–4015. https://doi.org/10.1158/0008-5472.CAN-06-4180
Article CAS PubMed Google Scholar
Visvader, J. E., & Lindeman, G. J. (2008). Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nature Reviews Cancer, 8(10), 755–768. https://doi.org/10.1038/nrc2499
Article CAS PubMed Google Scholar
Mohan, A., Raj, R. R., Mohan, G., KP, P., & Maliekal, T. T. (2021). Reporters of cancer stem cells as a tool for drug discovery. Frontiers in Oncology, 11, 669250. https://doi.org/10.3389/fonc.2021.669250
Article CAS PubMed PubMed Central Google Scholar
Sokol, S. Y. (2011). Maintaining embryonic stem cell pluripotency with Wnt signaling. Development, 138(20), 4341–4350. https://doi.org/10.1242/dev.066209
Article CAS PubMed PubMed Central Google Scholar
Merchant, A. A., & Matsui, W. (2010). Targeting Hedgehog–a cancer stem cell pathway. Clinical Cancer Research, 16(12), 3130–3140. https://doi.org/10.1158/1078-0432.CCR-09-2846
Article CAS PubMed PubMed Central Google Scholar
Zhu, Q., Shen, Y., Chen, X., He, J., Liu, J., & Zu, X. (2020). Self-renewal signalling pathway inhibitors: Perspectives on therapeutic approaches for cancer stem cells. Oncotargets and Therapy, 13, 525–540. https://doi.org/10.2147/OTT.S224465
Article CAS PubMed PubMed Central Google Scholar
Machold, R., Hayashi, S., Rutlin, M., Muzumdar, M. D., Nery, S., Corbin, J. G., et al. (2003). Sonic hedgehog is required for progenitor cell maintenance in telencephalic stem cell niches. Neuron, 39(6), 937–950. https://doi.org/10.1016/s0896-6273(03)00561-0
Article CAS PubMed Google Scholar
Takahashi-Yanaga, F., & Kahn, M. (2010). Targeting Wnt signaling: Can we safely eradicate cancer stem cells? Clinical Cancer Research, 16(12), 3153–3162. https://doi.org/10.1158/1078-0432.CCR-09-2943
Article CAS PubMed Google Scholar
Hadjimichael, C., Chanoumidou, K., Papadopoulou, N., Arampatzi, P., Papamatheakis, J., & Kretsovali, A. (2015). Common stemness regulators of embryonic and cancer stem cells. World J Stem Cells, 7(9), 1150–1184. https://doi.org/10.4252/wjsc.v7.i9.1150
Article PubMed PubMed Central Google Scholar
Rich, J. N. (2016). Cancer stem cells: Understanding tumor hierarchy and heterogeneity. Medicine (Baltimore), 95(1 Suppl 1), S2–S7. https://doi.org/10.1097/MD.0000000000004764
留言 (0)